To evaluate the clinical significance of CPEB1, p62 and NRF2 in pancreatic cancer, we collected tissue samples and clinical information from 90 patients with confirmed pancreatic ductal adenocarcinoma who underwent surgical resection. The gene discussed is SQSTM1; the disease is pancreatic ductal adenocarcinoma.